Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia

References

• Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(2):170–199. doi:10.6004/jnccn.2018.000629439178
   PubMed Web of Science ®Google Scholar
• Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and trends in endometrial cancer incidence, 1978–2013. J Natl Cancer Inst. 2018;110(4):354–361. doi:10.1093/jnci/djx21429045681
   PubMedGoogle Scholar
• Shaw E, Farris M, McNeil J, Friedenreich C. Obesity and endometrial cancer. Recent Results Cancer Res. 2016;208:107–136.27909905
   PubMedGoogle Scholar
• Terzic M, Norton M, Terzic S, Bapayeva G, Aimagambetova G. Fertility preservation in endometrial cancer patients: options, challenges and perspectives. Ecancermedicalscience. 2020;14:1030. doi:10.3332/ecancer.2020.103032419842
   PubMed Web of Science ®Google Scholar
• Casadio P, La Rosa M, Alletto A, et al. Fertility sparing treatment of endometrial cancer with and without initial infiltration of myometrium: a single center experience. Cancers. 2020;12(12):3571. doi:10.3390/cancers12123571
   PubMed Web of Science ®Google Scholar
• Soliman PT, Oh JC, Schmeler KM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005;105(3):575–580. doi:10.1097/01.AOG.0000154151.14516.f715738027
   PubMed Web of Science ®Google Scholar
• Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012;207(4):266.e1–12. doi:10.1016/j.ajog.2012.08.011
   Web of Science ®Google Scholar
• Li M, Guo T, Cui R, Feng Y, Bai H, Zhang Z. Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a systematic review and meta-analysis. Cancer Manag Res. 2019;11:4005–4021. doi:10.2147/CMAR.S19460731190979
   PubMed Web of Science ®Google Scholar
• Giampaolino P, Di Spiezio Sardo A, Mollo A, et al. Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study. J Minim Invasive Gynecol. 2019;26(4):648–656. doi:10.1016/j.jmig.2018.07.00130017893
   PubMed Web of Science ®Google Scholar
• Mazzon I, Corrado G, Masciullo V, Morricone D, Ferrandina G, Scambia G. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril. 2010;93(4):1286–1289. doi:10.1016/j.fertnstert.2008.12.00919700153
   PubMed Web of Science ®Google Scholar
• Yang B, Xu Y, Zhu Q, et al. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer. Gynecol Oncol. 2019;153(1):55–62. doi:10.1016/j.ygyno.2019.01.01430674421
   PubMed Web of Science ®Google Scholar
• Best D, Avenell A, Bhattacharya S. How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence. Hum Reprod Update. 2017;23(6):681–705. doi:10.1093/humupd/dmx02728961722
   PubMed Web of Science ®Google Scholar
• Wise MR, Jordan V, Lagas A, et al. Obesity and endometrial hyperplasia and cancer in premenopausal women: a systematic review. Am J Obstet Gynecol. 2016;214(6):689.e1–689.e17. doi:10.1016/j.ajog.2016.01.175
   PubMed Web of Science ®Google Scholar
• Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reproductive Biol Endocrinol. 2018;16(1):22. doi:10.1186/s12958-018-0336-z
   PubMed Web of Science ®Google Scholar
• Park JY, Seong SJ, Kim TJ, Kim JW, Bae DS, Nam JH. Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer. Gynecol Oncol. 2017;146(1):39–43. doi:10.1016/j.ygyno.2017.05.00228526167
   PubMed Web of Science ®Google Scholar
• Kiesel L, Eichbaum C, Baumeier A, Eichbaum M. Obesity epidemic - the underestimated risk of endometrial cancer. Cancers. 2020;12(12):3860. doi:10.3390/cancers12123860
   PubMed Web of Science ®Google Scholar
• Wei J, Zhang W, Feng L, Gao W. Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: a meta-analysis and systematic review. Medicine. 2017;96(37):e8034. doi:10.1097/MD.000000000000803428906392
   PubMed Web of Science ®Google Scholar
• Cholakian D, Hacker K, Fader AN, Gehrig PA, Tanner EJ. Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer. Gynecol Oncol. 2016;140(2):234–238. doi:10.1016/j.ygyno.2015.12.01026706662
   PubMed Web of Science ®Google Scholar
• Fink A, Cieslak S, Rosenbach F. Non-Pharmacological interventions for the prevention of weight gain in schizophrenic patients treated with antipsychotic medication. Psychiatr Prax. 2015;42(7):359–369. doi:10.1055/s-0035-155267026158719
   PubMed Web of Science ®Google Scholar
• Haggerty AF, Sarwer DB, Schmitz KH, Ko EM, Allison KC, Chu CS. Obesity and endometrial cancer: a lack of knowledge but opportunity for intervention. Nutr Cancer. 2017;69(7):990–995. doi:10.1080/01635581.2017.135931328937804
   PubMed Web of Science ®Google Scholar
• Yerevanian A, Soukas AA. Metformin: mechanisms in human obesity and weight loss. Curr Obes Rep. 2019;8(2):156–164. doi:10.1007/s13679-019-00335-330874963
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Human Reproduction. 2003;18(9):1928–1932. doi:10.1093/humrep/deg36712923151
   PubMed Web of Science ®Google Scholar
• Cavalcante MB, Sarno M, Peixoto AB, Araujo Júnior E, Barini R. Obesity and recurrent miscarriage: a systematic review and meta-analysis. J Obstet Gynaecol Res. 2019;45(1):30–38. doi:10.1111/jog.1379930156037
   PubMed Web of Science ®Google Scholar
• Kawwass JF, Kulkarni AD, Hipp HS, Crawford S, Kissin DM, Jamieson DJ. Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States. Fertil Steril. 2016;106(7):1742–1750. doi:10.1016/j.fertnstert.2016.08.02827666564
   PubMed Web of Science ®Google Scholar
• Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med. 2011;29(6):507–513. doi:10.1055/s-0031-129320422161463
   PubMed Web of Science ®Google Scholar
• Lowe MP, Cooper BC, Sood AK, Davis WA, Syrop CH, Sorosky JI. Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia. Gynecol Oncol. 2003;91(3):569–572. doi:10.1016/j.ygyno.2003.08.00714675678
   PubMed Web of Science ®Google Scholar
• Zhou R, Yang Y, Lu Q, et al. Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients. Gynecol Oncol. 2015;139(3):424–428. doi:10.1016/j.ygyno.2015.09.07826428941
   PubMed Web of Science ®Google Scholar
• Bozdag G, Yarali H, Polat M, Esinler I, Tiras B, Ayhan A. ICSI outcome following conservative fertility sparing management of endometrial cancer. Reprod Biomed Online. 2009;18(3):416–420. doi:10.1016/S1472-6483(10)60102-219298743
   PubMed Web of Science ®Google Scholar
• Kim MJ, Choe SA, Kim MK, Yun BS, Seong SJ, Kim YS. Outcomes of in vitro fertilization cycles following fertility-sparing treatment in stage IA endometrial cancer. Arch Gynecol Obstet. 2019;300(4):975–980. doi:10.1007/s00404-019-05237-231440822
   PubMed Web of Science ®Google Scholar
• Zapardiel I, Cruz M, Diestro MD, Requena A, Garcia-Velasco JA. Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers. Hum Reprod Update. 2016;22(3):281–305. doi:10.1093/humupd/dmv06626759231
   PubMed Web of Science ®Google Scholar
• Travaglino A, Raffone A, Saccone G, et al. Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: a systematic review. Acta Obstet Gynecol Scand. 2019;98(9):1086–1099. doi:10.1111/aogs.1358730793281
   PubMed Web of Science ®Google Scholar